Legislation recently introduced in the U.S. House aims to make compounded medications more accessible to patients. The Preserving Patient Access to Compounded Medications Act of 2017 (HR 2871), introduced by Reps. Morgan Griffith (R-VA) and Henry Cuellar (D-TX), would clarify the Drug Quality and Security Act in a way that would align the statute with congressional intent to balance public safety and patient access. Pharmacy organizations have applauded the bill's introduction. Douglas Hoey, CEO of the National Community Pharmacists Association, said his organization "supports Congress's efforts to assure appropriate oversight of compounding pharmacies in a way that does not curtail or hinder patient access to those specially-tailored medications." He added, "This common-sense, bipartisan legislative fix should be supported in the House of Representatives and a companion bill should be introduced in the Senate." The International Academy of Compounding Pharmacies also noted, "IACP consistently has said that maintaining access to potentially life-saving compounded medications is not only vital for patients; but, is consistent with the legislative intent of the DQSA."